MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
出版年份 2021 全文链接
标题
MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 11, Pages 2371
出版商
MDPI AG
发表日期
2021-05-28
DOI
10.3390/jcm10112371
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circulating MicroRNAs and Monocyte–Platelet Aggregate Formation in Acute Coronary Syndrome
- (2021) Stefan Stojkovic et al. THROMBOSIS AND HAEMOSTASIS
- Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels
- (2020) William A. E. Parker et al. Cardiovascular Diabetology
- Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel
- (2020) Dominick J. Angiolillo et al. JACC-Cardiovascular Interventions
- Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2020) Paul Guedeney et al. Journal of Clinical Medicine
- Plasma exosomal miRNAs involved in endothelial injury in microscopic polyangiitis patients
- (2020) Yang Wang et al. FASEB JOURNAL
- miR-125a-5p Regulates Megakaryocyte Proplatelet Formation Via the Actin Bundling Protein L-Plastin
- (2020) Seema Bhatlekar et al. BLOOD
- Platelet MicroRNA 365-3p Expression Correlates with High On-treatment Platelet Reactivity in Coronary Artery Disease Patients
- (2019) Yueh-Chung Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Clopidogrel Pharmacogenetics
- (2019) Naveen L. Pereira et al. Circulation-Cardiovascular Interventions
- Insufficient sleep is associated with a pro‐atherogenic circulating microRNA signature
- (2019) Jamie G. Hijmans et al. EXPERIMENTAL PHYSIOLOGY
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review
- (2019) Justyna Pordzik et al. Cardiovascular Diabetology
- Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out!
- (2019) Cindy L Grines et al. EUROPEAN HEART JOURNAL
- The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease
- (2019) Otto Mayer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atherosclerosis, myocardial infarction and primary hemostasis: Impact of platelets, von Willebrand factor and soluble glycoprotein VI
- (2019) Josepha-Maria Villmann et al. THROMBOSIS RESEARCH
- Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
- (2019) Marcelo A. Mori et al. Cell Metabolism
- MicroRNAs as a Potential Quality Measurement Tool of Platelet Concentrate Stored in Blood Banks—A Review
- (2019) Jersey Heitor da Silva Maués et al. Cells
- MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
- (2018) Marco Witkowski et al. Cardiovascular Diabetology
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
- (2018) Karen A. Hicks et al. CIRCULATION
- Transcoronary concentration gradients of circulating microRNAs in heart failure
- (2018) Salvatore De Rosa et al. EUROPEAN JOURNAL OF HEART FAILURE
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Platelet activity and hypercoagulation in type 2 diabetes
- (2018) Lesha Pretorius et al. Cardiovascular Diabetology
- Resistin is a prognostic factor for death in type 2 diabetes
- (2018) Agnieszka Kapłon‐Cieślicka et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients
- (2017) Antoni Bayés-Genis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS
- (2017) Li Peng et al. THROMBOSIS RESEARCH
- Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation
- (2017) Chang Xia et al. Journal of Diabetes Research
- Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk
- (2017) Zongwei Lin et al. Scientific Reports
- Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue FactorHighlights
- (2016) Marco Witkowski et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor
- (2016) Annarita Carino et al. Biomed Research International
- Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity but not to Genetic Polymorphisms within BDNF Encoding Gene in Patients with Type 2 Diabetes
- (2016) Ceren Eyileten et al. MEDICAL SCIENCE MONITOR
- Association of MicroRNAs and YRNAs With Platelet FunctionNovelty and Significance
- (2015) Dorothee Kaudewitz et al. CIRCULATION RESEARCH
- MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics
- (2015) J A Deiuliis INTERNATIONAL JOURNAL OF OBESITY
- MicroRNA deregulation in symptomatic carotid plaque
- (2015) Pierre Maitrias et al. JOURNAL OF VASCULAR SURGERY
- Next-generation re-sequencing of genes involved in increased platelet reactivity in diabetic patients on acetylsalicylic acid
- (2015) Marek Postula et al. PLATELETS
- miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease
- (2015) Christian Schulte et al. PLoS One
- Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review
- (2015) Varun Vaidya et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy
- (2015) Rui Shi et al. Biomed Research International
- Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report
- (2014) Bernadeta Chyrchel et al. PLATELETS
- Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: The AVOCADO study
- (2013) Marek Rosiak et al. Cardiology Journal
- Circulating MicroRNAs as Novel Biomarkers for Platelet Activation
- (2013) Peter Willeit et al. CIRCULATION RESEARCH
- Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra
- (2013) E. Cavarretta et al. EUROPEAN HEART JOURNAL
- Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease
- (2013) Hetty C. de Boer et al. EUROPEAN HEART JOURNAL
- Early leptin blockade predisposes fat-fed rats to overweight and modifies hypothalamic microRNAs
- (2013) Charlotte Benoit et al. JOURNAL OF ENDOCRINOLOGY
- Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention
- (2013) Xi-Yong Yu et al. EuroIntervention
- New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy
- (2012) Marek Postula et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Comparing the MicroRNA Spectrum between Serum and Plasma
- (2012) Kai Wang et al. PLoS One
- The Repertoire and Features of Human Platelet microRNAs
- (2012) Hélène Plé et al. PLoS One
- MicroRNAs in platelet biogenesis and function
- (2012) Seema Dangwal et al. THROMBOSIS AND HAEMOSTASIS
- Transcoronary Concentration Gradients of Circulating MicroRNAs
- (2011) Salvatore De Rosa et al. CIRCULATION
- Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes
- (2011) M. POSTULA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
- (2010) Anna Zampetaki et al. CIRCULATION RESEARCH
- The MicroRNA Spectrum in 12 Body Fluids
- (2010) J. A. Weber et al. CLINICAL CHEMISTRY
- Clopidogrel pathway
- (2010) Katrin Sangkuhl et al. Pharmacogenetics and Genomics
- Methods for the Measurement of Platelet Function
- (2009) Alan D. Michelson AMERICAN JOURNAL OF CARDIOLOGY
- miR-126 Regulates Angiogenic Signaling and Vascular Integrity
- (2008) Jason E. Fish et al. DEVELOPMENTAL CELL
- Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents
- (2008) Arun Natarajan et al. Diabetes & Vascular Disease Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now